High-Intensity Focused Ultrasound for Prostate Cancer: Novelty or Innovation?
JAMA
.
2016 Jun 28;315(24):2659-60.
doi: 10.1001/jama.2016.5002.
Authors
Jim C Hu
1
,
Aaron Laviana
2
,
Art Sedrakyan
3
Affiliations
1
Department of Urology, Weill Cornell Medicine, New York, New York.
2
Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California.
3
Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York.
PMID:
27367874
DOI:
10.1001/jama.2016.5002
No abstract available
MeSH terms
Data Collection
Decision Making
Device Approval
High-Intensity Focused Ultrasound Ablation*
Humans
Male
Prostatic Neoplasms / therapy*
Registries*
United States
United States Food and Drug Administration
Grants and funding
U01 FD005478/FD/FDA HHS/United States